Skip to content

Clinical trials

Phase 1/2 Triple Negative Breast Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Phase: Phase 1/2 Country / region: South Korea Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20182
20192
20201
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Amgen1
BicycleTx Limited1
Genexine, Inc.1
Gilead Sciences1
Medicenna Therapeutics, Inc.1
National Cancer Center, Korea1
Novartis Pharmaceuticals1
PMV Pharmaceuticals, Inc1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms11
Breast Neoplasms5
Squamous Cell Carcinoma of Head and Neck4
Carcinoma, Non-Small-Cell Lung3
Endometrial Neoplasms3
Melanoma3
Ovarian Neoplasms3
Stomach Neoplasms3
Carcinoma, Merkel Cell2
Carcinoma, Ovarian Epithelial2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.